drugset / Trial / NCT00533598

A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED)

NCT00533598 ↗

Phase 2 Completed Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the effects of MK0557 on body weight in obese subjects.

Timeline

Start
2002-09
Primary completion
2003-06
Completion
2003-06

Drugs

EvaluationDrugModalityDoseRoute
Subject MK0557 Small molecule — —

Indications